Molecular analysis of the mutational effects of Thai street rabies virus with increased virulence in mice after passages in the BHK cell line

Archives of Virology

Volumn 157, Issue 11, 2012, Pages 2201-2205

  Virojanapirom, Phatthamon ^a   Khawplod, Pakamatz ^b   Sawangvaree, Artikaya ^b   Wacharapluesadee, Supaporn ^a   Hemachudha, Thiravat ^a   Yamada, Kentaro ^c   Morimoto, Kinjiro ^d   Nishizono, Akira ^c  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^c OITA UNIVERSITY   (Japan)

^d YASUDA WOMEN'S UNIVERSITY   (Japan)

Author keywords

Non coding region; Non neuronal passage; Polyadenylation signal; Rabies virus; Virulence

Indexed keywords

UNTRANSLATED RNA; VIRUS PROTEIN; VIRUS RNA;

ANIMAL; ARTICLE; CELL LINE; DISEASE MODEL; DNA SEQUENCE; DOG; GENETICS; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; MISSENSE MUTATION; MOLECULAR GENETICS; MORTALITY; MOUSE; NUCLEOTIDE SEQUENCE; PATHOGENICITY; RABIES; RABIES VIRUS; SURVIVAL; THAILAND; VIROLOGY; VIRULENCE; VIRUS CULTURE;

ANIMALS; CELL LINE; DISEASE MODELS, ANIMAL; DNA MUTATIONAL ANALYSIS; DOGS; MICE; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; RABIES; RABIES VIRUS; RNA, UNTRANSLATED; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; SERIAL PASSAGE; SURVIVAL ANALYSIS; THAILAND; VIRAL PROTEINS; VIRULENCE;

MUS; RABIES VIRUS;

EID: 84868512745     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-012-1402-z     Document Type: Article

References (34)

1. Hemachudha T, Laothamatas J, Rupprecht CE (2002) Human rabies: a disease of complex neuropathogenetic mechanisms and diagnostic challenges. Lancet Neurol 1(2): 101-109.
2. Wunner WH (2007) Rabies virus. In: Jackson A, Wunner WH (eds) Rabies, 2nd edn. Elsevier, San Diego, pp 23-68.
3. Albertini AA, Ruigrok RW, Blondel D (2011) Rabies virus transcription and replication. Adv Virus Res 79: 1-22.
4. Okumura A, Harty RN (2011) Rabies virus assembly and budding. Adv Virus Res 79: 23-32.
5. Morimoto K, Hooper DC, Carbaugh H, Fu ZF, Koprowski H, Dietzschold B (1998) Rabies virus quasispecies: implications for pathogenesis. Proc Natl Acad Sci USA 95(6): 3152-3156.
6. Vos A, Neubert A, Aylan O, Schuster P, Pommerening E, Muller T, Chivatsi DC (1999) An update on safety studies of SAD B19 rabies virus vaccine in target and non-target species. Epidemiol Infect 123(1): 165-175.
7. Wu X, Smith TG, Rupprecht CE (2011) From brain passage to cell adaptation: the road of human rabies vaccine development. Expert Rev Vaccines 10(11): 1597-1608.
8. Sakamoto S, Ide T, Nakatake H, Tokiyoshi S, Yamamoto M, Kawai A, Smith JS (1994) Studies on the antigenicity and nucleotide sequence of the rabies virus Nishigahara strain, a current seed strain used for dog vaccine production in Japan. Virus Genes 8(1): 35-46.
9. Mita T, Shimizu K, Ito N, Yamada K, Ito Y, Sugiyama M, Minamoto N (2008) Amino acid at position 95 of the matrix protein is a cytopathic determinant of rabies virus. Virus Res 137(1): 33-39.
10. Khawplod P, Shoji Y, Ubol S, Mitmoonpitak C, Wilde H, Nishizono A, Kurane I, Morimoto K (2006) Genetic analysis of dog rabies viruses circulating in Bangkok. Infect Genet Evol 6(3): 235-240.
11. Prehaud C, Wolff N, Terrien E, Lafage M, Megret F, Babault N, Cordier F, Tan GS, Maitrepierre E, Menager P, Chopy D, Hoos S, England P, Delepierre M, Schnell MJ, Buc H, Lafon M (2010) Attenuation of rabies virulence: takeover by the cytoplasmic domain of its envelope protein. Sci Signal 3(105): ra5.
12. Schnell MJ, McGettigan JP, Wirblich C, Papaneri A (2010) The cell biology of rabies virus: using stealth to reach the brain. Nat Rev Microbiol 8(1): 51-61.
13. Grdzelishvili VZ, Smallwood S, Tower D, Hall RL, Hunt DM, Moyer SA (2005) A single amino acid change in the L-polymerase protein of vesicular stomatitis virus completely abolishes viral mRNA cap methylation. J Virol 79(12): 7327-7337.
14. Grdzelishvili VZ, Smallwood S, Tower D, Hall RL, Hunt DM, Moyer SA (2006) Identification of a new region in the vesicular stomatitis virus L polymerase protein which is essential for mRNA cap methylation. Virology 350(2): 394-405.
15. Smallwood S, Easson CD, Feller JA, Horikami SM, Moyer SA (1999) Mutations in conserved domain II of the large (L) subunit of the Sendai virus RNA polymerase abolish RNA synthesis. Virology 262(2): 375-383.
16. Schnell MJ, Conzelmann KK (1995) Polymerase activity of in vitro mutated rabies virus L protein. Virology 214(2): 522-530.
17. Faber M, Pulmanausahakul R, Nagao K, Prosniak M, Rice AB, Koprowski H, Schnell MJ, Dietzschold B (2004) Identification of viral genomic elements responsible for rabies virus neuroinvasiveness. Proc Natl Acad Sci USA 101(46): 16328-16332.
18. Beckert A, Geue L, Vos A, Neubert A, Freuling C, Muller T (2009) Genetic stability (in vivo) of the attenuated oral rabies virus vaccine SAD B19. Microbiol Immunol 53(1): 16-21.
19. Finke S, Cox JH, Conzelmann KK (2000) Differential transcription attenuation of rabies virus genes by intergenic regions: generation of recombinant viruses overexpressing the polymerase gene. J Virol 74(16): 7261-7269.
20. Wu X, Rupprecht CE (2008) Glycoprotein gene relocation in rabies virus. Virus Res 131(1): 95-99.
21. Stillman EA, Whitt MA (1997) Mutational analyses of the intergenic dinucleotide and the transcriptional start sequence of vesicular stomatitis virus (VSV) define sequences required for efficient termination and initiation of VSV transcripts. J Virol 71(3): 2127-2137.
22. Hwang LN, Englund N, Pattnaik AK (1998) Polyadenylation of vesicular stomatitis virus mRNA dictates efficient transcription termination at the intercistronic gene junctions. J Virol 72(3): 1805-1813.
23. Barr JN, Whelan SP, Wertz GW (1997) cis-Acting signals involved in termination of vesicular stomatitis virus mRNA synthesis include the conserved AUAC and the U7 signal for polyadenylation. J Virol 71(11): 8718-8725.
24. Cenna J, Hunter M, Tan GS, Papaneri AB, Ribka EP, Schnell MJ, Marx PA, McGettigan JP (2009) Replication-deficient rabies virus-based vaccines are safe and immunogenic in mice and nonhuman primates. J Infect Dis 200(8): 1251-1260.
25. Finke S, Mueller-Waldeck R, Conzelmann KK (2003) Rabies virus matrix protein regulates the balance of virus transcription and replication. J Gen Virol 84(Pt 6): 1613-1621.
26. Masatani T, Ito N, Shimizu K, Ito Y, Nakagawa K, Sawaki Y, Koyama H, Sugiyama M (2010) Rabies virus nucleoprotein functions to evade activation of the RIG-I-mediated antiviral response. J Virol 84(8): 4002-4012.
27. Masatani T, Ito N, Shimizu K, Ito Y, Nakagawa K, Abe M, Yamaoka S, Sugiyama M (2010) Amino acids at positions 273 and 394 in rabies virus nucleoprotein are important for both evasion of host RIG-I-mediated antiviral response and pathogenicity. Virus Res 155(1): 168-174.
28. Shoji Y, Inoue S, Nakamichi K, Kurane I, Sakai T, Morimoto K (2004) Generation and characterization of P gene-deficient rabies virus. Virology 318(1): 295-305.
29. Lafon M (2011) Evasive strategies in rabies virus infection. Adv Virus Res 79: 33-53.
30. Pulmanausahakul R, Li J, Schnell MJ, Dietzschold B (2008) The glycoprotein and the matrix protein of rabies virus affect pathogenicity by regulating viral replication and facilitating cell-to-cell spread. J Virol 82(5): 2330-2338.
31. Wang ZW, Sarmento L, Wang Y, Li XQ, Dhingra V, Tseggai T, Jiang B, Fu ZF (2005) Attenuated rabies virus activates, while pathogenic rabies virus evades, the host innate immune responses in the central nervous system. J Virol 79(19): 12554-12565.
32. Faber M, Faber ML, Li J, Preuss MA, Schnell MJ, Dietzschold B (2007) Dominance of a nonpathogenic glycoprotein gene over a pathogenic glycoprotein gene in rabies virus. J Virol 81(13): 7041-7047.
33. Wirblich C, Schnell MJ (2011) Rabies virus (RV) glycoprotein expression levels are not critical for pathogenicity of RV. J Virol 85(2): 697-704.
34. Javier RT, Rice AP (2011) Emerging Theme: Cellular PDZ proteins as common targets of pathogenic viruses. J Virol 85(22): 11544-11556.